Fiera Capital Corp Nektar Therapeutics Transaction History

Fiera Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 02, 2018	SELL	$46.25 - $104.45 $3.53 Million - $7.98 Million	-76,367 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$57.4 - $108.44 $3.48 Million - $6.57 Million	-60,614 Reduced 44.25%	76,367 $8.12 Million
Q4 2017 Feb 09, 2018	SELL	$23.02 - $60.5 $641,360 - $1.69 Million	-27,861 Reduced 16.9%	136,981 $8.18 Million
Q3 2017 Nov 13, 2017	BUY	$17.79 - $24.0 $2.93 Million - $3.96 Million	164,842	164,842 $3.96 Million

15.6M

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $10.6B
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.